The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19

A Attiq, LJ Yao, S Afzal, MA Khan - International immunopharmacology, 2021 - Elsevier
Abstract The coronavirus disease (COVID-19) has once again reminded us of the
significance of host immune response and consequential havocs of the immune …

COVID19 biomarkers: What did we learn from systematic reviews?

S Semiz - Frontiers in cellular and infection microbiology, 2022 - frontiersin.org
The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …

Diabetes mellitus, energy metabolism, and COVID-19

C Conte, E Cipponeri, M Roden - Endocrine Reviews, 2024 - academic.oup.com
Obesity, diabetes mellitus (mostly type 2), and COVID-19 show mutual interactions because
they are not only risk factors for both acute and chronic COVID-19 manifestations, but also …

Rapid and effective vitamin D supplementation may present better clinical outcomes in COVID-19 (SARS-CoV-2) patients by altering serum INOS1, IL1B, IFNg …

MS Gönen, M Alaylıoğlu, E Durcan, Y Özdemir, S Şahin… - Nutrients, 2021 - mdpi.com
Background: We aimed to establish an acute treatment protocol to increase serum vitamin D,
evaluate the effectiveness of vitamin D3 supplementation, and reveal the potential …

The S1 subunit of the SARS-CoV-2 spike protein activates human monocytes to produce cytokines linked to COVID-19: relevance to galectin-3

JT Schroeder, AP Bieneman - Frontiers in immunology, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), rapidly evolved into a pandemic–the likes of which has not …

Olive leaves as a potential phytotherapy in the treatment of COVID-19 disease; A mini-review

SM Abdelgawad, MAE Hassab… - Frontiers in …, 2022 - frontiersin.org
Beginning from December 2019, widespread COVID-19 has caused huge financial
misfortunes and exceptional wellbeing emergencies across the globe. Discovering an …

Interleukin-18 is a potential biomarker to discriminate active adult-onset still's disease from COVID-19

PK Chen, JL Lan, PH Huang, JL Hsu… - Frontiers in …, 2021 - frontiersin.org
Background Hyperinflammation with dysregulated production of galectins and cytokines
may develop in COVID-19 or adult-onset Still's disease (AOSD). Given the similar clinical …

[HTML][HTML] SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases

R Larionova, K Byvaltsev, О Kravtsova, E Takha… - Journal of Translational …, 2022 - Elsevier
The clinical and immunological spectrum of acute and post-active COVID-19 syndrome
overlaps with criteria used to characterize autoimmune diseases such as rheumatoid …

Altered lipid profile in COVID-19 patients and metabolic reprogramming

T Zhao, C Wang, B Duan, P Yang, J Wu… - Frontiers in …, 2022 - frontiersin.org
Background Coronavirus disease 2019 (COVID-19) is a global pandemic. Previous studies
have reported dyslipidemia in patients with COVID-19. Herein, we conducted a retrospective …

The impact of maternal prenatal stress related to the COVID-19 pandemic during the first 1000 days: a historical perspective

S Schoenmakers, EJ Verweij, R Beijers… - International Journal of …, 2022 - mdpi.com
The COVID-19 pandemic has a major impact on society, particularly affecting its vulnerable
members, including pregnant women and their unborn children. Pregnant mothers reported …